Compound ID | 2467
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Protein synthesis inhibitor. Inhibits LTA synthesis by binding to PgcA and downregulating PgsA; Lipoteichoic acid synthesis inhibitor |
| Target Pathogen: | Active against Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Enterococcus faecalis, Enterococcus faecium, and Listeria monocytogenes |
| Description: | Synthetic compound; cytotoxic to mammalian cells only at 64-256x MIC |
| Institute where first reported: | Chemistry Department, Institute for Drug Discovery, Purdue University, West Lafayette, Indiana 47907, United States; Purdue Institute of Inflammation, Immunology, and Infectious Disease, Purdue University, West Lafayette, Indiana 47907, United States |
| Year first mentioned: | 2022 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/146173597 |
| Citations: |
|
| Patent: | WO2019199496A1 |